ENANTA PHARMACEUTICALS, INC Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
ENANTA PHARMACEUTICALS, INC (ENTA) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$193.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-12
- ENANTA PHARMACEUTICALS, INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$193.00K.
- ENANTA PHARMACEUTICALS, INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$405.00K.
- ENANTA PHARMACEUTICALS, INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $10.00K.
- ENANTA PHARMACEUTICALS, INC other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $63.00K, a 93.40% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was -$641.00K, a 143.43% decline from fiscal 2024.
- ENANTA PHARMACEUTICALS, INC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $1.48M, a 42.12% decline from fiscal 2023.
- ENANTA PHARMACEUTICALS, INC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $2.55M.
- ENANTA PHARMACEUTICALS, INC other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$3.34M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$193.00K 10-Q · filed 2026-08-12 | -$598.00K derived: sum of 2 quarters · filed 2026-08-12 | -$588.00K 10-Q · filed 2026-08-12 | -$525.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$405.00K 10-Q · filed 2026-08-12 | -$395.00K 10-Q · filed 2026-05-13 | -$332.00K derived: sum of 3 quarters · filed 2026-08-12 | -$510.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $10.00K 10-Q · filed 2026-08-12 | $73.00K derived: sum of 2 quarters · filed 2026-08-12 | -$105.00K derived: sum of 3 quarters · filed 2026-08-12 | -$300.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-09-30 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | -$115.00K derived: sum of 2 quarters · filed 2026-08-12 | -$310.00K derived: sum of 3 quarters · filed 2026-08-12 | -$641.00K 10-K · filed 2025-11-19 |
| 2025-06-30 | -$178.00K 10-Q · filed 2026-08-12 | -$373.00K derived: sum of 2 quarters · filed 2026-08-12 | -$704.00K 10-Q · filed 2026-08-12 | $251.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$195.00K 10-Q · filed 2026-08-12 | -$526.00K 10-Q · filed 2026-05-13 | $429.00K derived: sum of 3 quarters · filed 2026-08-12 | $443.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2024-12-31 | -$331.00K 10-Q · filed 2026-08-12 | $624.00K derived: sum of 2 quarters · filed 2026-08-12 | $638.00K derived: sum of 3 quarters · filed 2026-08-12 | $505.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2024-09-30 | $955.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | $969.00K derived: sum of 2 quarters · filed 2025-11-19 | $836.00K derived: sum of 3 quarters · filed 2025-11-19 | $1.48M 10-K · filed 2025-11-19 |
| 2024-06-30 | $14.00K 10-Q · filed 2025-08-13 | -$119.00K derived: sum of 2 quarters · filed 2025-08-13 | $521.00K 10-Q · filed 2025-08-13 | $851.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-03-31 | -$133.00K 10-Q · filed 2025-08-13 | $507.00K 10-Q · filed 2025-05-14 | $837.00K derived: sum of 3 quarters · filed 2025-11-19 | $1.15M derived: sum of 4 quarters · filed 2025-11-19 |
| 2023-12-31 | $640.00K 10-Q · filed 2025-08-13 | $970.00K derived: sum of 2 quarters · filed 2025-11-19 | $1.28M derived: sum of 3 quarters · filed 2025-11-19 | $2.14M derived: sum of 4 quarters · filed 2025-11-19 |
| 2023-09-30 | $330.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | $641.00K derived: sum of 2 quarters · filed 2025-11-19 | $1.50M derived: sum of 3 quarters · filed 2025-11-19 | $2.55M 10-K · filed 2025-11-19 |
| 2023-06-30 | $311.00K 10-Q · filed 2024-08-07 | $1.17M derived: sum of 2 quarters · filed 2024-08-07 | $2.22M 10-Q · filed 2024-08-07 | $2.12M derived: sum of 4 quarters · filed 2024-11-27 |
| 2023-03-31 | $860.00K 10-Q · filed 2024-08-07 | $1.91M 10-Q · filed 2024-05-08 | $1.80M derived: sum of 3 quarters · filed 2024-11-27 | $1.22M derived: sum of 4 quarters · filed 2024-11-27 |
| 2022-12-31 | $1.05M 10-Q · filed 2024-08-07 | $945.00K derived: sum of 2 quarters · filed 2024-11-27 | $362.00K derived: sum of 3 quarters · filed 2024-11-27 | -$1.67M derived: sum of 4 quarters · filed 2024-11-27 |
| 2022-09-30 | -$104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27 | -$687.00K derived: sum of 2 quarters · filed 2024-11-27 | -$2.72M derived: sum of 3 quarters · filed 2024-11-27 | -$3.34M 10-K · filed 2024-11-27 |
| 2022-06-30 | -$583.00K 10-Q · filed 2023-08-08 | -$2.61M derived: sum of 2 quarters · filed 2023-08-08 | -$3.24M 10-Q · filed 2023-08-08 | -$3.36M derived: sum of 4 quarters · filed 2023-11-22 |
| 2022-03-31 | -$2.03M 10-Q · filed 2023-08-08 | -$2.65M 10-Q · filed 2023-05-09 | -$2.77M derived: sum of 3 quarters · filed 2023-11-22 | -$3.09M derived: sum of 4 quarters · filed 2023-11-22 |
| 2021-12-31 | -$624.00K 10-Q · filed 2023-08-08 | -$742.00K derived: sum of 2 quarters · filed 2023-11-22 | -$1.06M derived: sum of 3 quarters · filed 2023-11-22 | -$1.41M derived: sum of 4 quarters · filed 2023-11-22 |
| 2021-09-30 | -$118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-22 | -$437.00K derived: sum of 2 quarters · filed 2023-11-22 | -$787.00K derived: sum of 3 quarters · filed 2023-11-22 | -$1.23M 10-K · filed 2023-11-22 |
| 2021-06-30 | -$319.00K 10-Q · filed 2022-08-08 | -$669.00K derived: sum of 2 quarters · filed 2022-08-08 | -$1.11M 10-Q · filed 2022-08-08 | -$1.72M derived: sum of 4 quarters · filed 2022-11-23 |
| 2021-03-31 | -$350.00K 10-Q · filed 2022-08-08 | -$789.00K 10-Q · filed 2022-05-09 | -$1.40M derived: sum of 3 quarters · filed 2022-11-23 | -$553.00K derived: sum of 4 quarters · filed 2022-11-23 |
| 2020-12-31 | -$439.00K 10-Q · filed 2022-08-08 | -$1.05M derived: sum of 2 quarters · filed 2022-11-23 | -$203.00K derived: sum of 3 quarters · filed 2022-11-23 | $171.00K derived: sum of 4 quarters · filed 2022-11-23 |
| 2020-09-30 | -$614.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-23 | $236.00K derived: sum of 2 quarters · filed 2022-11-23 | $610.00K derived: sum of 3 quarters · filed 2022-11-23 | $698.00K 10-K · filed 2022-11-23 |
| 2020-06-30 | $850.00K 10-Q · filed 2021-08-09 | $1.22M derived: sum of 2 quarters · filed 2021-08-09 | $1.31M 10-Q · filed 2021-08-09 | $1.29M derived: sum of 4 quarters · filed 2021-11-24 |
| 2020-03-31 | $374.00K 10-Q · filed 2021-08-09 | $462.00K 10-Q · filed 2021-05-10 | $445.00K derived: sum of 3 quarters · filed 2021-11-24 | $620.00K derived: sum of 4 quarters · filed 2021-11-24 |
| 2019-12-31 | $88.00K 10-Q · filed 2021-08-09 | $71.00K derived: sum of 2 quarters · filed 2021-11-24 | $246.00K derived: sum of 3 quarters · filed 2021-11-24 | $491.00K derived: sum of 4 quarters · filed 2021-11-24 |
| 2019-09-30 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24 | $158.00K derived: sum of 2 quarters · filed 2021-11-24 | $403.00K derived: sum of 3 quarters · filed 2021-11-24 | $544.00K 10-K · filed 2021-11-24 |
| 2019-06-30 | $175.00K 10-Q · filed 2020-08-10 | $420.00K derived: sum of 2 quarters · filed 2020-08-10 | $561.00K 10-Q · filed 2020-08-10 | $758.00K derived: sum of 4 quarters · filed 2020-11-25 |
| 2019-03-31 | $245.00K 10-Q · filed 2020-08-10 | $386.00K 10-Q · filed 2020-05-11 | $583.00K derived: sum of 3 quarters · filed 2020-11-25 | $782.00K derived: sum of 4 quarters · filed 2020-11-25 |
| 2018-12-31 | $141.00K 10-Q · filed 2020-08-10 | $338.00K derived: sum of 2 quarters · filed 2020-11-25 | $537.00K derived: sum of 3 quarters · filed 2020-11-25 | $201.00K derived: sum of 4 quarters · filed 2020-11-25 |
| 2018-09-30 | $197.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-25 | $396.00K derived: sum of 2 quarters · filed 2020-11-25 | $60.00K derived: sum of 3 quarters · filed 2020-11-25 | -$286.00K 10-K · filed 2020-11-25 |
| 2018-06-30 | $199.00K 10-Q · filed 2019-08-09 | -$137.00K derived: sum of 2 quarters · filed 2019-08-09 | -$483.00K 10-Q · filed 2019-08-09 | |
| 2018-03-31 | -$336.00K 10-Q · filed 2019-08-09 | -$682.00K 10-Q · filed 2019-05-10 | ||
| 2017-12-31 | -$346.00K 10-Q · filed 2019-08-09 | |||
| 2017-09-30 | -$131.00K 10-K · filed 2019-11-27 | |||
| 2016-09-30 | -$14.00K 10-K · filed 2018-11-29 | |||
| 2015-09-30 | $133.00K 10-K · filed 2017-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |